» Articles » PMID: 11544290

Diverse Transcriptional Response of CD4+ T Cells to Stromal Cell-derived Factor SDF-1: Cell Survival Promotion and Priming Effects of SDF-1 on CD4+ T Cells

Overview
Journal J Immunol
Date 2001 Sep 7
PMID 11544290
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Stromal cell-derived factor (SDF)-1 is a ligand for the chemokine receptor CXCR4 which is broadly expressed in lymphocytes, but the effects of SDF-1 on T cells are largely unknown. When examined using complementary DNA microarray, up-regulation of genes which are associated with DNA repair, detoxification, apoptosis, cell morphology, cell adhesion, and signal transduction was seen in CD4(+) T cells upon SDF-1 exposure. SDF-1 was shown to promote CD4(+) T cell survival through the phosphatidylinositol 3-kinase (PI3K)- and mitogen-activated protein kinase (MAPK)-cascades without cell cycle progression. The proapoptotic Bcl-2 antagonistic of cell death protein was also seen inactivated by the SDF-1-mediated activation of MAPK-extracellular signal-regulated kinases (MEK)-extracellular signal-regulated kinase-ribosomal S6 kinases- and PI3K-pathways. Moreover, the genes known to be associated with cell survival were up-regulated upon SDF-1 exposure and were linked to the MAPK-MEK and PI3K-pathways. Thus, SDF-1 promotes cell survival by two mechanisms: posttranslational inactivation of the cell death machinery and an increased transcription of cell survival-related genes. SDF-1 also primed resting CD4(+) T cells for cytokine- and TCR-mediated stimuli. These data suggest that the SDF-1-mediated cell survival combined with its priming function would set T cells to respond to immunologic challenges.

Citing Articles

Contribution of cuproptosis and immune-related genes to idiopathic pulmonary fibrosis disease.

Jin C, Li J, Li Q, Zhang L, Zheng S, Feng Q Front Immunol. 2025; 16:1458341.

PMID: 39991151 PMC: 11842377. DOI: 10.3389/fimmu.2025.1458341.


The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke.

Darban Y, Askari H, Ghasemi-Kasman M, Yavarpour-Bali H, Dehpanah A, Gholizade P Curr Neuropharmacol. 2024; 22(14):2368-2383.

PMID: 39403058 PMC: 11451314. DOI: 10.2174/1570159X22666240603084558.


Bactericidal ability of target acidic phospholipids and phagocytosis of CDC42 GTPase-mediated cytoskeletal rearrangement underlie functional conservation of CXCL12 in vertebrates.

Zhang Y, Xia N, Hu Y, Zhu W, Yang C, Su J Sci China Life Sci. 2024; 67(12):2713-2729.

PMID: 39279006 DOI: 10.1007/s11427-023-2625-7.


CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata.

Zheng M, Kim M, Park S, Kim W, Oh S, Sung J Int J Mol Sci. 2024; 25(3).

PMID: 38338982 PMC: 10855715. DOI: 10.3390/ijms25031705.


Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer.

Gao Z, Fang Z, Yuan J, Sun S, Li B Front Immunol. 2023; 14:1188351.

PMID: 37564657 PMC: 10410148. DOI: 10.3389/fimmu.2023.1188351.